Australia markets closed

Cellectis S.A. (CLLS)

NasdaqGM - NasdaqGM Delayed price. Currency in USD
Add to watchlist
2.6500-0.0200 (-0.75%)
At close: 04:00PM EDT
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-85,010
-106,139
-114,197
-81,074
Depreciation & amortisation
18,068
18,435
14,156
7,834
Deferred income taxes
452
87
0
0
Stock-based compensation
999
6,043
11,493
10,028
Change in working capital
-9,234
-5,723
-12,297
-17,323
Accounts receivable
1,077
-3,187
-13,091
-2,542
Inventory
-
0
215
100
Accounts payable
-2,797
3,247
177
5,688
Other working capital
-66,738
-89,885
-123,118
-124,684
Other non-cash items
5,231
8,627
-6,530
13,767
Net cash provided by operating activities
-65,683
-87,444
-104,562
-80,261
Cash flows from investing activities
Investments in property, plant and equipment
-1,055
-2,441
-18,556
-44,423
Purchases of investments
-
-
-143
-2,117
Sales/maturities of investments
463
126
15,000
4,997
Other investing activities
-
-
-1
-1
Net cash used for investing activities
-2,021
-2,761
7,279
-54,342
Cash flows from financing activities
Debt repayment
-16,169
-12,354
-10,641
-4,737
Common stock issued
-
-
44,638
9,205
Common stock repurchased
-469
-569
-
-
Dividends paid
0
0
0
0
Other financing activities
-
-
1
-1
Net cash used provided by (used for) financing activities
34,716
-7,505
45,230
19,747
Net change in cash
-31,461
-89,060
-49,758
-107,281
Cash at beginning of period
97,648
185,636
241,148
340,522
Cash at end of period
66,188
93,216
185,636
241,148
Free cash flow
Operating cash flow
-65,683
-87,444
-104,562
-80,261
Capital expenditure
-1,055
-2,441
-18,556
-44,423
Free cash flow
-66,738
-89,885
-123,118
-124,684